# Study of Screening Brain MRIs in Stage IV Breast Cancer

> **NCT05115474** · PHASE2 · RECRUITING · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 170 (estimated)

## Conditions studied

- Triple Negative Breast Cancer
- HER2-positive Breast Cancer
- Hormone Receptor-positive Breast Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Magnetic Resonance Imaging

## Key facts

- **NCT ID:** NCT05115474
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-21
- **Primary completion:** 2026-06-16
- **Final completion:** 2026-10
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2026-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05115474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05115474, "Study of Screening Brain MRIs in Stage IV Breast Cancer". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT05115474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*